$150MSeries D, 4 September 2025
Funds advance multiple clinical programs into Phase 1b and Phase 2 trials; total raised $517M.
- Amount
- $150M
- Stage
- Series D
- Announced
- 4 September 2025
- Lead
- Premji Invest
- Other investors
- Baillie Gifford, Kinnevik, Lux Capital
- Use of funds
- Funds advance multiple clinical programs into Phase 1b and Phase 2 trials; total raised $517M.
- Checked
- Announced by the company
- Sources
- Enveda Raises $150M Series D Funding to Reach Unicorn Status, Enrolls First Patient in Lead Program, and Adds businesswire.com
Enveda Raises $150M Series D Funding to Reach Unicorn Status, Enrolls First Patient in Lead Program, and Adds news.google.com